Oligonucleotides in Therapeutics (Recorded version)

AGENDA:

Oligonucleotide Therapeutics: the Future is Now – an Ionis Story Richard Geary

Innovative and Effective Workflow Solutions for Oligonucleotides from Purification to Analysis Bill Evans

Living in the World of RNAi Therapeutics Mano Manoharan


CHAIRMAN:

89db6db11486ab874c781e0efb908c95.png

Marc Lemaître

Oligonucleotide Therapeutics CMC/Strategy Consultant

SPEAKERS:

e0e933d255d41098d52813aa19c6a3a1.png

Richard S. Geary

Executive Vice President of Drug Development at Ionis Pharmaceuticals

c05dbbabb4202c532dd6a97cf89df4ca.png

Bill Evans

Downstream Process Development Scientist - Tosoh Bioscience

13418a6be10452b03c4b7415b8f6c7b6.png

Mano Manoharan

Senior Vice President, Innovation Chemistry & Alnylam Distinguished Scientist - Alnylam Pharmaceuticals

Fill in the form and watch the recorded version

Main Sponsor: